- Symptomatic treatment of recurrent vertigo with/without cochlear signs
- Symptomatic treatment of vestibular vertigo
- Meniere Syndrome characterized by: vertigo, hearing loss or tinnitus
PO 8-16mg TDS
Tablet: 8mg
To be taken with food
Partial H1receptor agonist and H3 receptor antagonist. Non-sedative.
- Nausea
- Dyspepsia
- Headaches
- Hypersensitivity reactions
- Hypersensitivity to components
- Pheochromocytoma
- MAOIs
Drug Status
Availability | Prescription or OTC by Pharmacist |
Pregnancy | Unknown; Weigh risk vs benefit |
Breastfeeding | Unknown; Weigh risk vs benefit |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Besdiz | 16mg | Tablet | 30’s | Medisel Kenya | Medisel Kenya |
Besdiz | 16mg | Tablet | 30’s | Medisel Kenya | Medisel Kenya |
Be-Stedy | 16mg | Tablet | 100’s | Aurobindo Pharma | Simba Pharma |
Be-Stedy | 24mg | Tablet | 100’s | Aurobindo Pharma | Simba Pharma |
Betaserc | 8mg | Tablet | 100’s | Abbott Labs | Harley’s Ltd |
Betavert | 16mg | Tablet | 100’s | Sun Pharma | Sun Pharma |
Betavert | 24mg | Tablet | 50’s | Sun Pharma | Sun Pharma |
Vertease | 16mg | Tablet | 30s | Pharmevo | Harley’s Ltd |